Key Insights

Highlights

Success Rate

99% trial completion (above average)

Published Results

12 trials with published results (14%)

Research Maturity

74 completed trials (85% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.1%

1 terminated out of 87 trials

Success Rate

98.7%

+12.2% vs benchmark

Late-Stage Pipeline

2%

2 trials in Phase 3/4

Results Transparency

16%

12 of 74 completed with results

Key Signals

12 with results99% success

Data Visualizations

Phase Distribution

83Total
Not Applicable (33)
Early P 1 (5)
P 1 (42)
P 2 (1)
P 3 (1)
P 4 (1)

Trial Status

Completed74
Unknown5
Recruiting3
Withdrawn2
Enrolling By Invitation1
Not Yet Recruiting1

Trial Success Rate

98.7%

Benchmark: 86.5%

Based on 74 completed trials

Clinical Trials (87)

Showing 20 of 20 trials
NCT07345130Phase 1Completed

A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions

NCT05774704Phase 1RecruitingPrimary

Curcumin and Retinal Study

NCT07063173Not ApplicableRecruitingPrimary

Bioavailability of Ration Items Containing Tart Cherry Extract

NCT06481709Phase 1CompletedPrimary

Study on Sapropterin Dihydrochloride Oral Suspension in Healthy Subjects

NCT05263895Phase 1CompletedPrimary

Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation

NCT05627518Phase 1Completed

Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation

NCT05361369Phase 1CompletedPrimary

Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule

NCT06758778Not ApplicableEnrolling By InvitationPrimary

CreNeuroS™️CNS Fish Oil Plus Softgels Compared to Vascepa® Capsules and Deplin® Capsules in a Pharmacokinetic, Single Dose Evaluation on Healthy Adult Human Subjects Under Fasting Conditions

NCT06177483Not ApplicableCompletedPrimary

Bioavailability Evaluation of CurQ+ Curcumin Formulation

NCT06563856Phase 1CompletedPrimary

A Study of TEPEZZA Subcutaneous Administration in Healthy Adults

NCT06306911Not ApplicableRecruitingPrimary

Bioavailability of Aronia Melanocarpa

NCT05263921Phase 1CompletedPrimary

Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants

NCT06427681Early Phase 1Not Yet RecruitingPrimary

An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

NCT06214338Not ApplicableCompletedPrimary

Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)

NCT04139928Not ApplicableCompletedPrimary

Bioavailability of Single-dose Magnesium Salts

NCT05826899Not ApplicableCompletedPrimary

A Stable Isotope Study to Evaluate the Bioavailability of an Oat Protein-based Iron Delivery System

NCT06043739Phase 1CompletedPrimary

Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects

NCT06098001Not ApplicableUnknownPrimary

Bioavailability Study of Hemp Phenolics

NCT05835258Not ApplicableCompletedPrimary

Oral Bioavailability of Two Melatonin Supplements

NCT05967377Phase 1Completed

Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Subjects

Scroll to load more

Research Network

Activity Timeline